Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-08

Clinical Trial Update: Outcomes of Arterial Allografts Preserved at +2 to +8°C for Revascularization in Septic Settings

View source ↗

Summary

An update on a clinical trial evaluating arterial allografts preserved at 2–8°C for revascularization in septic or potentially septic environments; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Revascularization in a Septic or Potentially Septic Environment | Status: ACTIVE_NOT_RECRUITING